Home › Companies › CYTOKINETICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and CYTOKINETICS INC.’s Form 8-K, filed 2024-05-17 (Item 5.07 on EDGAR). Page generated 04 October 2026.
Explore CYTOKINETICS INC. in the interactive database Compare manager voting policies
These tallies are CYTOKINETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-17 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Robert I. Blum | 87,317,169 | -- | -- | 2,214,926 | 6,649,555 | Majority: yes |
| Elect Director: Robert A. Harrington, M.D. | 78,347,186 | -- | -- | 11,184,909 | 6,649,555 | Majority: yes |
| Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common stock | 88,586,473 | 481,098 | 464,524 | -- | 6,649,555 | Majority: yes |
| Proposal 3: Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 The stockholders ratified the appointment by the Audit Committee of the Board of Directors of Ernst & | 95,957,265 | 97,750 | 126,635 | -- | -- | Majority: yes |
| Proposal 4: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the 2024 Proxy Statement | 85,814,395 | 2,927,007 | 790,693 | -- | 6,649,555 | Majority: yes |
Source: CYTOKINETICS INC., Form 8-K, filed with the SEC on 2024-05-17 — read the filing on EDGAR.
Each item below shows how the 372 asset managers that disclosed a CYTOKINETICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CYTOKINETICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 16 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
CYTOKINETICS INC.’s own tally for this item (“Proposal 4: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the 2024 Proxy Statement”): 85,814,395 for, 2,927,007 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 101,637,922 outstanding shares: 84% for, 3% against (87% of the company cast a for/against vote).
The 370 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 22,430,375 | 0 | 0 | 0 | For |
| T. Rowe Price | 13,140,862 | 0 | 0 | 0 | For |
| Vanguard | 11,982,653 | 0 | 0 | 0 | For |
| BlackRock | 8,015,002 | 1,007 | 0 | 0 | For |
| State Street | 4,813,713 | 0 | 0 | 0 | For |
| Wellington | 3,500,779 | 0 | 0 | 0 | For |
| AllianceBernstein | 2,199,609 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 2,136,401 | 0 | 0 | 0 | For |
| Invesco | 1,664,237 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,651,409 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 1,574,825 | 0 | 0 | 0 | For |
| Charles Schwab | 1,574,364 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,328,012 | 0 | 0 | 0 | For |
| ARMISTICE CAPITAL, LLC | 1,122,944 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 1,054,721 | 0 | 0 | 0 | For |
| Northern Trust | 1,043,873 | 70 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 847,132 | 0 | 0 | 0 | For |
| Janus Henderson | 845,459 | 0 | 0 | 0 | For |
| American Century | 0 | 736,507 | 0 | 0 | Against |
| Putnam | 716,430 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 650,748 | 0 | 0 | 0 | For |
| Man Group plc | 626,970 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 624,390 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 585,102 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 578,965 | 0 | 0 | 0 | For |
Showing the 25 largest of 370 asset managers. See all 370 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
CYTOKINETICS INC.’s own tally for this item (“Proposal 2: Approval of the Amendment and Restatement of the Amended and Restated 2015 Employee Stock Purchase Plan to increase the number of shares authorized for issuance under such plan by 300,000 shares of common sto”): 88,586,473 for, 481,098 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 101,637,922 outstanding shares: 87% for, 0.5% against (88% of the company cast a for/against vote).
The 106 asset managers below cast 99.7% of the shares they voted on this item FOR (45,529,775 for, 121,254 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,718,091 | 0 | 0 | 0 | For |
| Fidelity | 11,284,181 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,327,500 | 0 | 0 | 0 | For |
| BlackRock | 4,940,809 | 0 | 0 | 0 | For |
| State Street | 1,433,892 | 0 | 0 | 0 | For |
| Charles Schwab | 773,948 | 0 | 0 | 0 | For |
| Invesco | 755,177 | 0 | 0 | 0 | For |
| AllianceBernstein | 579,626 | 0 | 0 | 0 | For |
| Jackson National | 563,981 | 0 | 0 | 0 | For |
| Equitable | 500,252 | 0 | 0 | 0 | For |
| TIAA | 406,286 | 0 | 0 | 0 | For |
| American Century | 362,286 | 0 | 0 | 0 | For |
| Putnam | 351,320 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 331,998 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 329,175 | 0 | 0 | 0 | For |
| Hartford | 322,627 | 0 | 0 | 0 | For |
| Brighthouse | 277,297 | 41,994 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 296,787 | 0 | 0 | 0 | For |
| Principal | 263,129 | 24,931 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 254,148 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 245,071 | 0 | 0 | 0 | For |
| Aberdeen | 232,967 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 223,405 | 0 | 0 | 0 | For |
| John Hancock | 220,155 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 210,455 | 0 | 0 | 0 | For |
Showing the 25 largest of 106 asset managers. See all 106 in the interactive database.
Combines 5 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
CYTOKINETICS INC.’s own tally for this item (“Elect Director: Robert I. Blum”): 87,317,169 for, 2,214,926 withheld, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 101,637,922 outstanding shares: 86% for, 2% withheld (88% of the company cast a for/withheld vote).
The 103 asset managers below cast 100% of the shares they voted on this item FOR (45,466,794 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,718,091 | 0 | 0 | 0 | For |
| Fidelity | 11,284,181 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,327,500 | 0 | 0 | 0 | For |
| BlackRock | 4,940,809 | 0 | 0 | 0 | For |
| State Street | 1,433,892 | 0 | 0 | 0 | For |
| Charles Schwab | 773,948 | 0 | 0 | 0 | For |
| Invesco | 755,177 | 0 | 0 | 0 | For |
| AllianceBernstein | 579,626 | 0 | 0 | 0 | For |
| Jackson National | 563,981 | 0 | 0 | 0 | For |
| Equitable | 500,252 | 0 | 0 | 0 | For |
| TIAA | 406,286 | 0 | 0 | 0 | For |
| American Century | 362,286 | 0 | 0 | 0 | For |
| Putnam | 351,320 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 331,998 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 329,175 | 0 | 0 | 0 | For |
| Hartford | 322,627 | 0 | 0 | 0 | For |
| Brighthouse | 277,297 | 0 | 41,994 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 296,787 | 0 | 0 | 0 | For |
| Principal | 263,129 | 0 | 24,931 | 0 | For |
| MUTUAL FUND SERIES TRUST | 254,148 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 245,071 | 0 | 0 | 0 | For |
| Aberdeen | 232,967 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 223,405 | 0 | 0 | 0 | For |
| John Hancock | 220,155 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 210,455 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
CYTOKINETICS INC.’s own tally for this item (“Proposal 3: Ratification of Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2024 The stockholders ratified the appointment by the Audit Commit”): 95,957,265 for, 97,750 against, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 101,637,922 outstanding shares: 94% for, 0.1% against (95% of the company cast a for/against vote).
The 103 asset managers below cast 99.9% of the shares they voted on this item FOR (45,580,233 for, 316 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 11,718,091 | 0 | 0 | 0 | For |
| Fidelity | 11,284,181 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,327,500 | 0 | 0 | 0 | For |
| BlackRock | 4,940,809 | 0 | 0 | 0 | For |
| State Street | 1,433,892 | 0 | 0 | 0 | For |
| Charles Schwab | 773,948 | 0 | 0 | 0 | For |
| Invesco | 755,177 | 0 | 0 | 0 | For |
| AllianceBernstein | 579,626 | 0 | 0 | 0 | For |
| Jackson National | 563,981 | 0 | 0 | 0 | For |
| Equitable | 500,252 | 0 | 0 | 0 | For |
| TIAA | 406,286 | 0 | 0 | 0 | For |
| American Century | 362,286 | 0 | 0 | 0 | For |
| Putnam | 351,320 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 331,998 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 329,175 | 0 | 0 | 0 | For |
| Hartford | 322,627 | 0 | 0 | 0 | For |
| Brighthouse | 277,297 | 0 | 41,994 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 296,787 | 0 | 0 | 0 | For |
| Principal | 288,060 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 254,148 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 245,071 | 0 | 0 | 0 | For |
| Aberdeen | 232,967 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 223,405 | 0 | 0 | 0 | For |
| John Hancock | 220,155 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 210,455 | 0 | 0 | 0 | For |
Showing the 25 largest of 103 asset managers. See all 103 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% fund support · no official result
The 67 asset managers below cast 100% of the shares they voted on this item FOR (32,736,452 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 11,264,851 | 0 | 19,330 | 0 | For |
| Vanguard | 9,723,957 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 5,327,500 | 0 | Abstain |
| BlackRock | 4,940,809 | 0 | 0 | 0 | For |
| State Street | 1,433,892 | 0 | 0 | 0 | For |
| Invesco | 755,177 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 579,626 | 0 | Abstain |
| Equitable | 186,356 | 0 | 313,896 | 0 | Abstain |
| TIAA | 406,286 | 0 | 0 | 0 | For |
| American Century | 362,286 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 329,175 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 296,787 | 0 | Abstain |
| Principal | 140,706 | 0 | 146,781 | 0 | Abstain |
| Brighthouse | 203,017 | 0 | 74,279 | 0 | For |
| MUTUAL FUND SERIES TRUST | 254,148 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 245,071 | 0 | 0 | 0 | For |
| Aberdeen | 232,967 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 210,455 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 190,384 | 0 | 0 | 0 | For |
| BNY Mellon | 187,789 | 0 | 0 | 0 | For |
| Northern Trust | 168,717 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 167,454 | 0 | 0 | 0 | For |
| MassMutual | 31,140 | 0 | 130,000 | 0 | Abstain |
| Lord Abbett | 158,921 | 0 | 0 | 0 | For |
| Lincoln Financial | 141,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
CYTOKINETICS INC.’s own tally for this item (“Elect Director: Robert A. Harrington, M.D.”): 78,347,186 for, 11,184,909 withheld, per its Form 8-K filed 2024-05-17 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 101,637,922 outstanding shares: 77% for, 11% withheld (88% of the company cast a for/withheld vote).
The 46 asset managers below cast 100% of the shares they voted on this item FOR (5,543,678 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,994,134 | 0 | 0 | 0 | For |
| Charles Schwab | 773,948 | 0 | 0 | 0 | For |
| Jackson National | 385,281 | 0 | 178,700 | 0 | For |
| Putnam | 351,320 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 331,998 | 0 | 0 | 0 | For |
| Hartford | 322,627 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 223,405 | 0 | 0 | 0 | For |
| John Hancock | 196,033 | 0 | 24,122 | 0 | For |
| HARBOR FUNDS | 175,610 | 0 | 0 | 0 | For |
| Russell Investments | 150,698 | 0 | 0 | 0 | For |
| JPMorgan | 125,756 | 0 | 0 | 0 | For |
| Northwestern Mutual | 73,377 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 56,950 | 0 | 0 | 0 | For |
| Empower | 44,907 | 0 | 0 | 0 | For |
| Global X | 42,334 | 0 | 0 | 0 | For |
| Brighthouse | 1 | 0 | 41,994 | 0 | Abstain |
| SEI | 39,645 | 0 | 0 | 0 | For |
| Neuberger Berman | 38,748 | 0 | 0 | 0 | For |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 37,952 | 0 | Abstain |
| MML SERIES INVESTMENT FUND | 31,480 | 0 | 0 | 0 | For |
| Allianz | 30,638 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 28,415 | 0 | 0 | 0 | For |
| Mercer Funds | 24,960 | 0 | 0 | 0 | For |
| Tema ETF Trust | 24,454 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 15,268 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Ranked by the number of CYTOKINETICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 101,637,922 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 22.07% |
| 2 | T. Rowe Price | 12.93% |
| 3 | Vanguard | 11.79% |
| 4 | BlackRock | 7.89% |
| 5 | State Street | 4.74% |
| 6 | Wellington | 3.44% |
| 7 | AllianceBernstein | 2.16% |
| 8 | Vestal Point Capital, LP | 2.10% |
| 9 | Invesco | 1.64% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.62% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with BlackRock, Inc. | 15.84% | DEF14A |
| BlackRock | 15.28% | 13F |
| FMR (Fidelity) | 12.88% | 13F |
| Entities affiliated with Fidelity Investments | 12.80% | DEF14A |
| Vanguard Group | 11.67% | 13F |
| Entities affiliated with Wellington Management Group LLP | 6.43% | DEF14A |
| State Street | 4.45% | 13F |
| Wellington Management | 3.92% | 13F |
| T. Rowe Price | 2.88% | 13F |
| Geode Capital | 2.21% | 13F |
Percentages above are of 101,637,922 shares outstanding, as reported by CYTOKINETICS INC. on its Form 10-K dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTOKINETICS INC.’s 10-K dated 2023-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.
At CYTOKINETICS INC.'s shareholder meeting held 2024-05-15, in the 2023-2024 proxy season, 372 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,594 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CYTOKINETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-17.
CYTOKINETICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.